These evidences support Reg3 acting as a portative role in maintaining the immune‐homeostasis in the IBD condition, and the restoration of Reg3 levels by 2′‐FL indicated the relief of the inflammatory process and attenuation of dysbiosis in the colon of colitis mice in response to 2′‐FL treatment. This evidence concerns the gene REG3A and colitis.